sábado, 20 de febrero de 2021

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients - The Lancet

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients - The Lancet

No hay comentarios:

Publicar un comentario